Efficacy and safety of onabotulinumtoxinA in pediatric patients with chronic migraine

被引：0
|
作者：
Caronna, E. [1 ]
Mas-de-les-Valls-Cerco, R. [1 ]
Gallardo, V. J. [1 ]
Gomez-Dabo, L. [1 ]
Alpuente, A. [1 ]
Torres-Ferrus, M. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Hosp & Res Inst, Dept Neurol, Headache Clin, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P158
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey Manack
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [32] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 74 - 74
  • [33] OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
    Aurora, S. K.
    Dodick, D. W.
    Diener, H. -C.
    DeGryse, R. E.
    Turkel, C. C.
    Lipton, R. B.
    Silberstein, S. D.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (01): : 61 - 70
  • [34] The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta-analysis
    Lindsay, Rebecca
    Kalifa, Amira
    Kuziek, Jonathan
    Kabbouche, Marielle
    Hershey, Andrew D.
    Orr, Serena L.
    HEADACHE, 2024, 64 (10): : 1200 - 1216
  • [35] Efficacy and safety of levetiracetam in pediatric migraine
    Miller, GS
    HEADACHE, 2004, 44 (03): : 238 - 243
  • [36] OnabotulinumtoxinA Treatment Satisfaction among Patients with Chronic Migraine
    Tockhorn-Heidenreich, A.
    Ford, J.
    Jackson, J.
    Ye, W. Wenyu
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 891 - 891
  • [37] CHRONIC MIGRAINE IN THE ELDERLY: EXPERIENCE WITH ONABOTULINUMTOXINA IN 25 PATIENTS
    Camina, J.
    Molina, F. J.
    CEPHALALGIA, 2018, 38 : 98 - 98
  • [38] Development of onabotulinumtoxinA for chronic migraine
    Whitcup, Scott M.
    Turkel, Catherine C.
    DeGryse, Ronald E.
    Brin, Mitchell F.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013, 2014, 1329 : 67 - 80
  • [39] OnabotulinumtoxinA for the Treatment of Chronic Migraine
    Rothrock, John F.
    HEADACHE, 2011, 51 (04): : 659 - 660
  • [40] Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age
    Papetti, Laura
    Frattale, Ilaria
    Ursitti, Fabiana
    Sforza, Giorgia
    Monte, Gabriele
    Ferilli, Michela Ada Noris
    Tarantino, Samuela
    Proietti Checchi, Martina
    Valeriani, Massimiliano
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
12345